| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 7507844 | Drug and Alcohol Dependence | 2012 | 10 Pages | 
Abstract
												These data suggest that the oxymorphone DCR formulations may be a promising technology for reducing opioid abuse.
											Related Topics
												
													Life Sciences
													Neuroscience
													Behavioral Neuroscience
												
											Authors
												Suzanne K. Vosburg, Jermaine D. Jones, Jeanne M. Manubay, Judy B. Ashworth, Irma H. Benedek, Sandra D. Comer, 
											